Articles

1. Correction to: 3D bioprinted tumor model: a prompt and convenient platform for overcoming immunotherapy resistance by recapitulating the tumor microenvironment

   • Zhanyi Zhang
   • Xuebo Chen
   • Shengnan Ren

   Correction Open access 30 April 2024

2. Targeting Dectin-1 and or VISTA enhances anti-tumor immunity in melanoma but not colorectal cancer model

   • Siavash Mashhouri
   • Amirhossein Rahmati
   • Shokrollah Elahi

   Research Open access 26 April 2024

   

3. Rituximab potentially improves clinical outcomes of CAR-T therapy for r/r B-ALL via sensitizing leukemia cells to CAR-T-mediated cytotoxicity and reducing CAR-T exhaustion

   • Yangzi Li
   • Qingya Cui
   • Xiaowen Tang

   Research Open access 25 April 2024

   

4. LILRB2 promotes immune escape in breast cancer cells via enhanced HLA-A degradation

   • Zhiyuan Jiang
   • Qianru Huang
   • Hui Zhao

   Research 24 April 2024

   

5. Chordoma cells possess bone-dissolving activity at the bone invasion front

   • Katsuhiro Kawaai
   • Yumiko Oishi
   • Koichi Matsuo

   Research Open access 23 April 2024

   

6. Exploring the impact of PDGFD in osteosarcoma metastasis through single-cell sequencing analysis

   • Yujing Huang
   • Dongyan Cao
   • Aina He

   Research Open access 23 April 2024

   

7. Correction to: Microbial metabolite trimethylamine-N-oxide induces intestinal carcinogenesis through inhibiting farnesoid X receptor signaling

   • Wanru Zhang
   • Xiali Qin
   • Hailong Cao

   Correction 16 April 2024

   

8. Integrated analysis of single-cell RNA-seq and bulk RNA-seq reveals immune suppression subtypes and establishes a novel signature for determining the prognosis in lung adenocarcinoma

   • Shengqiang Mao
   • Yilong Wang
   • Li Zhang

   Research 15 April 2024

   

9. The emerging role of CARM1 in cancer

   • Zizhuo Xie
   • Yuan Tian
   • Na Xie

   Review Open access 15 April 2024

   

10. Establishment, characterization, and biobanking of 36 pancreatic cancer organoids: prediction of metastasis in resectable pancreatic cancer

    • Soon-Chan Kim
    • Ha-Young Seo
    • Ja-Lok Ku

    Research Open access 15 April 2024

    

11. Downregulation of GPX8 in hepatocellular carcinoma: impact on tumor stemness and migration

    • Chen-Yang Tao
    • Xiao-Ling Wu
    • Jia Fan

    Research Open access 12 April 2024

    

12. Dexmedetomidine promotes colorectal cancer progression via Piwil2 signaling

    • Jing Dong
    • Ji Che
    • Jun Zhang

    Research 09 April 2024

    

13. Hedgehog ligand and receptor cooperatively regulate EGFR stability and activity in non-small cell lung cancer

    • Aidi Huang
    • Junyao Cheng
    • Minzhang Cheng

    Research 03 April 2024

    

14. Copy number signatures and CCNE1 amplification reveal the involvement of replication stress in high-grade endometrial tumors oncogenesis

    • Regine Marlin
    • Jean-Samuel Loger
    • Mehdi Jean-Laurent

    Research Open access 02 April 2024

    

15. Efficacy of programmed cell death 1 inhibitor maintenance after chimeric antigen receptor T cells in patients with relapsed/refractory B-cell non-Hodgkin-lymphoma

    • Xiangke Xin
    • Xiaojian Zhu
    • Yicheng Zhang

    Research 02 April 2024

    

16. IFIT1 modulates the proliferation, migration and invasion of pancreatic cancer cells via Wnt/β-catenin signaling

    • Tian-Hao Li
    • Bang-Bo Zhao
    • Wei-Bin Wang

    Research 27 March 2024

    

17. 3D bioprinted tumor model: a prompt and convenient platform for overcoming immunotherapy resistance by recapitulating the tumor microenvironment

    • Zhanyi Zhang
    • Xuebo Chen
    • Shengnan Ren

    Review Open access 23 March 2024

    

18. DNA hypomethylation patterns and their impact on the tumor microenvironment in colorectal cancer

    • He Huang
    • Qian Li
    • Chunlian Ke

    Research 23 March 2024

    

19. Multi-dimensional characterization of apoptosis in the tumor microenvironment and therapeutic relevance in melanoma

    • Jing Ye
    • Benliang Wei
    • Hong Liu

    Research Open access 19 March 2024

    

20. The Ribonuclease ZC3H12A is required for self-inflicted DNA breaks after DNA damage in small cell lung cancer cells

    • Mingjun Lu
    • Qing Gao
    • Teng Ma

    Correspondence 18 March 2024

    

21. Mapping the immune terrain in lung adenocarcinoma progression: Tfh-like cells in tertiary lymphoid structures

    • Jialei Gong
    • Di Yu

    Comment 16 March 2024

    

22. Identification of a novel gene signature related to prognosis and metastasis in gastric cancer

    • Joseba Elizazu
    • Aizpea Artetxe-Zurutuza
    • Estefania Carrasco-Garcia

    Research Open access 13 March 2024

    

23. CAFs vs. TECs: when blood feuds fuel cancer progression, dissemination and therapeutic resistance

    • Diane Coursier
    • Fernando Calvo

    Review Open access 07 March 2024

    

24. STK3 kinase activation inhibits tumor proliferation through FOXO1-TP53INP1/P21 pathway in esophageal squamous cell carcinoma

    • Ziying Zhao
    • Yuan Chu
    • Meidong Xu

    Research Open access 04 March 2024

    

25. The predictive significance of chromobox family members in prostate cancer in humans

    • Xiaoting Xu
    • Cong Lai
    • Kewei Xu

    Research 01 March 2024

    

26. The prognostic effect of tumor-associated macrophages in stage I-III colorectal cancer depends on T cell infiltration

    • Umair Majid
    • Christian Holst Bergsland
    • Ragnhild A. Lothe

    Research Open access 26 February 2024

    

27. Nilotinib in combination with sunitinib renders MCL-1 for degradation and activates autophagy that overcomes sunitinib resistance in renal cell carcinoma

    • Tingyu Liu
    • Xin Yue
    • Ran-Yi Liu

    Research 23 February 2024

    

28. PIN1 promotes the metastasis of cholangiocarcinoma cells by RACK1-mediated phosphorylation of ANXA2

    • Yuming Wang
    • Yiwei Liu
    • Xiaofeng Wu

    Research 22 February 2024

    

29. GDF15 induces chemoresistance to oxaliplatin by forming a reciprocal feedback loop with Nrf2 to maintain redox homeostasis in colorectal cancer

    • Haiping Lin
    • Yang Luo
    • Ming Zhong

    Research 22 February 2024

    

30. O-GlcNAcylation of TRIM29 and OGT translation forms a feedback loop to promote adaptive response of PDAC cells to glucose deficiency

    • Fu-Ying Zhao
    • Xue Chen
    • Hua-Qin Wang

    Research 12 February 2024

    

31. Emerging roles of deubiquitinating enzymes in actin cytoskeleton and tumor metastasis

    • Ying Xue
    • Cong Xue
    • Wei Song

    Review 07 February 2024

    

32. Repaglinide restrains HCC development and progression by targeting FOXO3/lumican/p53 axis

    • Yifei Tan
    • Yongjie Zhou
    • Jiayin Yang

    Research 07 February 2024

    

33. Pathological response and tumor stroma immunogenic features predict long-term survival in non-small cell lung cancer after neoadjuvant chemotherapy

    • Shuaibo Wang
    • Xujie Sun
    • Lin Yang

    Research 06 February 2024

    

34. Targeting MEK/COX-2 axis improve immunotherapy efficacy in dMMR colorectal cancer with PIK3CA overexpression

    • Kunwei Peng
    • Yongxiang Liu
    • Liangping Xia

    Research 05 February 2024

    

35. OTUB1 accelerates hepatocellular carcinoma by stabilizing RACK1 via its non-canonical ubiquitination

    • Liqun Peng
    • Tiangen Wu
    • Yufeng Yuan

    Research Open access 05 February 2024

    

36. A novel risk score system based on immune subtypes for identifying optimal mRNA vaccination population in hepatocellular carcinoma

    • Hongkai Zhuang
    • Chenwei Tang
    • Yajin Chen

    Research 05 February 2024

    

37. DNA-methylome-derived epigenetic fingerprint as an immunophenotype indicator of durable clinical immunotherapeutic benefits in head and neck squamous cell carcinoma

    • Rui Li
    • Xin Wen
    • Xin-Ran Tang

    Research 05 February 2024

    

38. Microbial metabolite trimethylamine-N-oxide induces intestinal carcinogenesis through inhibiting farnesoid X receptor signaling

    • Wanru Zhang
    • Xiali Qin
    • Hailong Cao

    Research 05 February 2024

    

39. Robust detection of clinically relevant features in single-cell RNA profiles of patient-matched fresh and formalin-fixed paraffin-embedded (FFPE) lung cancer tissue

    • Alexandra Trinks
    • Miha Milek
    • Philip Bischoff

    Research Open access 01 February 2024

    

40. Omics-based molecular classifications empowering in precision oncology

    • Zhaokai Zhou
    • Ting Lin
    • Zaoqu Liu

    Review 31 January 2024

    

41. NK cells as powerful therapeutic tool in cancer immunotherapy

    • Mao Huang
    • Yixuan Liu
    • Wei Xiong

    Review 03 January 2024

    

42. Extracellular vesicles related gene HSPH1 exerts anti-tumor effects in prostate cancer via promoting the stress response of CD8 + T cells

    • Xinrui Wu
    • Yinjie Zhu
    • Jiahua Pan

    Brief Report 02 January 2024

    

43. Asymmetric post-translational modifications regulate the nuclear translocation of STAT3 homodimers in response to leukemia inhibitory factor

    • Mickael Diallo
    • Constança Pimenta
    • Federico Herrera

    Brief Report Open access 27 December 2023

    

44. ITGB2-ICAM1 axis promotes liver metastasis in BAP1-mutated uveal melanoma with retained hypoxia and ECM signatures

    • Jiaoduan Li
    • Dongyan Cao
    • Dongxi Xiang

    Research 27 December 2023

    

45. Sirtuin 5-mediated deacetylation of TAZ at K54 promotes melanoma development

    • Garam Kim
    • Poshan Yugal Bhattarai
    • Hong Seok Choi

    Research 19 December 2023

    

46. ATF3-induced activation of NF-κB pathway results in acquired PARP inhibitor resistance in pancreatic adenocarcinoma

    • Yang Liu
    • Yizhi Cao
    • Baiyong Shen

    Research 15 December 2023

    

47. DNA repair in tumor radioresistance: insights from fruit flies genetics

    • Antonella Porrazzo
    • Matteo Cassandri
    • Giovanni Cenci

    Review 14 December 2023

    

48. CSGALNACT2 restricts ovarian cancer migration and invasion by modulating MAPK/ERK pathway through DUSP1

    • Mingjun Ma
    • Chao Wang
    • Yu Wang

    Research Open access 12 December 2023

    

49. The development of in vitro organotypic 3D vulvar models to study tumor-stroma interaction and drug efficacy

    • Shidi Wu
    • Bertine W. Huisman
    • Abdoelwaheb El Ghalbzouri

    Research 07 December 2023

    

50. SUMOylation inhibitors activate anti-tumor immunity by reshaping the immune microenvironment in a preclinical model of hepatocellular carcinoma

    • Zengbin Wang
    • Banglun Pan
    • Nanhong Tang

    Research 06 December 2023